Rats bred to abuse alcohol accumulated numerous genetic differences, many of which occurred in regulatory regions of the genome, reports Feng C. Zhou at Indiana University in Indianapolis and William Muir at Purdue University in West Lafayette Indiana, and colleagues in a study published on August 4 in PLOS Genetics.
There is a high rate of prescription pain reliever abuse in Europe, largely accounted by opioids, according to the first comparative study of prescription drug abuse in the European Union, which was conducted by researchers at RTI International and published in BMC Psychiatry.
AACC welcomed thousands of medical professionals and healthcare leaders at the 68th AACC Annual Scientific Meeting & Clinical Lab Expo in Philadelphia from July 31–August 4. The meeting featured pioneering advances in medical testing research and technology that will help patients get accurate diagnoses and more effective treatment.
As of Wednesday, August 3, a total of 20,000 laboratory medicine professionals had registered for the meeting, which is a 14% increase over meeting attendance in 2015 and the highest number of attendees that have come to the meeting in the last four years. More attendees are expected today, the last day of the meeting.
The Tutela Genesis II Temperature Monitoring System is the most intuitive and robust system yet from Tutela. Find out why so many have chosen Tutela to monitor their priceless inventory.
GlycoMark, Inc. announced it has partnered with Diazyme Laboratories to offer the first diabetes panel to test three different measures of glycemic control on one specimen. The panel includes assays that measure both intermediate-term and long-term glucose averages (Diazyme’s Glycated Serum Protein/GSP and Enzymatic HbA1c) along with GlycoMark—a test specifically related to hyperglycemia over a one- to two-week period. The announcement was made at the 68th AACC Annual Scientific Meeting and Clinical Lab Expo.
The first of its kind alliance provides Augusta University’s medical center with unprecedented access to the full suite of diagnostic products and world-class business services available from Beckman Coulter’s parent company, Danaher Corporation.
This product allows you to test different particles to find which yield optimal performance characteristics in your specific system including cell isolations, affinity purifications, immunoassays, molecular assays.
Tutela Monitoring Systems has been providing web-based scientific wireless temperature monitoring systems for over 20 years. Our customers trust us as their valued partner for their temperature monitoring needs.
AutoSorter™ 1200 is Yaskawa Motoman’s newest high-speed sorting instrument for pre- and post-analytic specimen processing. Leveraging the previous model’s excellent record for reliability and speed, AutoSorter 1200 raises the bar on throughput at up to 1,200 tubes/hr.
Yaskawa Motoman’s AutoSorter™ 2000BB bulk sorter has a new configuration available that can maintain frozen specimens in a -20°C environment during the sorting process. This enables automated sorting of most frozen specimens which previously required labor-intensive and error-prone manual handling.
Loyola researchers have discovered a potential new health concern related to excessive alcohol consumption.Adults who drink excessively were found to have less nitric oxide in their exhaled breath than adults who don’t drink. Nitric oxide helps protect against certain harmful bacteria.
Gold Standard Diagnostics, Corp. (GSD) announces a strategic alliance with R-Biopharm AG (Darmstadt, Germany) to collaborate on multiple technology and marketing initiatives that will leverage the companies’ respective strengths in expanding product offerings and geographic sales coverage.
The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) sets global standard in collaboration with other international organizations as harmonization of methods in laboratory medicine is a means to improve patient safety
eAcademy aims to make high quality educational modules available to Laboratory professionals and will provide a resource for individuals in their training, as well as for those involved in the planning and organisation of educational programmes.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, today announced its entry into the rapidly growing molecular diagnostics testing market with the launch of Amplichek™ II quality control, which was recently issued a de novo clearance from the U.S. Food and Drug Administration (FDA).
The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) as leading organization in the field of Clinical Chemistry and Laboratory Medicine worldwide, strives to enhance the scientific level and the quality of diagnosis and therapy for patients throughout the world.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a
global provider of life science research and clinical diagnostic products, today announced its continued expansion into the molecular diagnostics testing market with the launch of Amplichek™ I quality control, which was recently issued a 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, today announced the launch of two human recombinant antigens, expanding the company’s portfolio of Critical Raw Materials for the in vitro diagnostics market.
Based on the proven ASP sample processing platform extended with a specially designed card handler addcare provides an automated solution for Gel Card based applications.
AUDIT MicroControls, Inc. is pleased to announce the following new addition to our complete line of calibration verification/linearity and daily quality control products: Linearity FD BNP (Extended). This product is intended to simulate human patient serum samples for the purpose of determining linearity, calibration verification and verification of reportable range.
Awareness Technology, manufacturer of diagnostic ELISA, CLIA, Biochemistry, and ISE instruments and reagents announces the restructuring of its UAE branch office to improve access for all Asian markets.
Addcare Bio-Tech provides advanced liquid handling systems, automated immunoassay workstations and customized systems. We create solutions for a wide range of applications by combining our proprietary liquid handling technology with a variety of platforms and modules, each designed to handle a specific task in the configuration.
Awareness Technology, manufacturer of diagnostic ELISA, CLIA, Biochemistry, and ISE instruments and reagents, completed the development of ChemWell® 2. The new analyzer represents an evolution of the ChemWell® line of fully automated instruments applying the company’s innovative single-plate technology to a two-plate system. Unlike similar devices capable of processing both ELISA and CLIA assays in 96-well micro plates, ChemWell®2 offers increased flexibility to laboratory professionals by allowing random placement of ELISA and CLIA microstrips even within the same plate.
Awareness Technology, manufacturer of diagnostic ELISA, CLIA, and Biochemistry instruments and reagents announces the worldwide launch of a new analyzer for measuring serum concentrations of sodium, potassium and chloride as a companion product to its line of biochemistry analyzers. Selectalyte, which is available both as a stand-alone instrument and as a module, was developed after many years of working with other similar devices and incorporating a number of significant improvements to ease of use, electrode stability, overall durability, precision, and convenience. The instrument and all its consumables, including a tri-level set of controls, are manufactured at Awareness Technology.
Biomatrica, Inc., a producer of reagents and devices for sample collection and analysis in diagnostics systems, nucleic acid testing, and biobanking, announced today that it has received certification from British Standards Institution Group America, Inc. that the company complies with the requirements of ISO 13485:2003 for an integrated quality management system across all functions of the business, from design and development to manufacturing and supply.
Boule Diagnostics AB has won a significant share of public tenders for a total of 329 hematology systems in Mexico in partnership with its Mexican distributors. The instruments will be delivered at the end of the second quarter and beginning of third quarter 2016. Some smaller follow-up orders are expected during the third quarter. The purchasing organisations have been IMSS (Instituto Mexicano del Seguro Social), the largest and most important public health system in the country, and ISSSTE (Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado), the second largest public system in charge of providing health services to government employees.
Compact KNF boxer diaphragm pumps feature an efficient two-heads-one-motor configuration. The alternating head operation results in smooth, level flow, reducing the need for additional dampening components for systems sensitive to pulsation. In an alternative mode, two different liquids are transferred simultaneously, eliminating the need for a second pump.
KNF Neuberger introduces the “Big Sucker diaphragm pump, a high flow pump specifically designed for liquid/air mixture applications, such as emptying well plates and waste-liquid containers.
Maccura Biotechnology Co., Ltd. was incorporated in 1994. It focuses on In-Vitro Diagnostic reagents’ development, manufacture, marketing and service.
Maccura is a hi-tech enterprise certified by relevant departments. Maccura has past the CMD ISO13485, CQC ISO14001, TUV ISO13485 as well as CE Certification of some products, and obtained the CNAS Medical Reference Laboratory Accreditation.
We are participating 68th(2016) AACC Annual Scientific Meeting and Clinical Lab Expo in Pennsylvania convention center, Philadelphia. PA. USA. during August 2~4 and we will have a special presentation for press conference. This opportunity is given to the reputed companies and our products.
Ortho Clinical Diagnostics will present seven scientific posters on its assays and display six products at the 2016 American Association for Clinical Chemistry (AACC) annual meeting. Ortho’s posters will address a range of important tests, both marketed and in-development for clinical labs.
Puritan is pleased to announce that the German Patent and Trademark Office (GPTO) has handed Puritan and its customers a win in cancellation proceedings initiated on Puritan’s behalf against Copan’s utility model DE 20 2004 021 932 U1 (DE’932). Specifically, in DE File No. 20 2004 021 932.8, the GPTO has declared DE’932 invalid for its entire term, effectively erasing the patent as if it never existed. This means Copan may not base any claims on any alleged infringement of DE’932.
On June 3rd, 2015, in the oral hearing before the Board of Appeals of the European Patent Office (EPO), the EPO has issued its final decision regarding Copan’s European Patent EP 1 608 268 B1 (“EP’268”). The Board of Appeals of the EPO confirmed that Copan’s EP’268 is only valid in a scope which is substantially narrower than the claim set as originally granted.
Puritan Medical Products, North America’s largest manufacturer of swabs and specimen collection devices, is pleased to announce Opti-Tranz™ and Opti-Tranz™ Plus, a brand new line of traditional liquid and agar gel collection and transport systems for bacteriological applications.
Puritan Medical Products Co. LLC, an American manufacturer of single¬-use medical, diagnostic, forensic and critical environment products for the global market, was awarded two U.S. patents for their HydraFlock® and PurFlock Ultra® swabs, issued March 1 and 8, respectively.
Roche today announced approval of the VENTANA PD-L1 (SP142) Assay1 by the US Food and Drug Administration (FDA) as a complementary diagnostic to provide PD-L1 status on patients who are considering treatment with the FDA approved Roche immunotherapy TECENTRIQ™ (atezolizumab) for metastatic urothelial cancer (mUC). This test is the first to evaluate patient PD-L1 status using immune cell staining and scoring within the tumor microenvironment, providing clinicians with information that may guide immunotherapy decisions2.
New comer from Africa with outstanding technology of clinical chemistry ready to use single liquid reagents with powerful stand alone portable analyzers for A1c , HB, Bilirubin in babies , as well as a full lab solution station establishing 2003 with trustworthy R&D Effort Egyptian Company for Biotechnology with the brand name "Spectrum Diagnostics" is specialized in development, manufacturing and marketing top quality IVD Spectrum develops and manufactures high quality in vitro diagnostic reagents.
Sekisui Diagnostics becomes exclusive commercial partner for the Qualigen FastPack® IP System in the U.S. and international markets. Sekisui Diagnostics to expand point of care testing portfolio with the FastPack® IP System from Qualigen Inc. Qualigen expands their commercial reach through relationship with Sekisui Diagnostics
Tecan has introduced the D300e Digital Dispenser* for applications that need faster, reliable dispensing down to picoliter volumes. This innovative, simple-to-use device is ideal for the creation of assay plates, and can cut set-up times from hours or days to just minutes. Users can choose between dispensing aqueous solutions in combination with a surfactant – for the investigation of proteins, antibodies, enzymes and nucleic acids – and DMSO, for small molecule studies, offering greater flexibility for life sciences workflows.
Tecan has launched the Spark® 20M multimode microplate reader*, offering tailor-made solutions to suit virtually any drug discovery or advanced life science research application. This freely configurable system gives researchers access to new techniques and features intended to enhance and streamline biochemical and cell-based workflows. At the heart of the instrument are Spark’s unique Fusion Optics and a powerful, high frequency xenon flash lamp, which can be combined with your choice of high performance detection modules to ensure a perfect match for your workflow. Options include an enhanced fluorescence module designed to improve sensitivity and increase the speed of high throughput screening, and the newly developed Te-Cool™ cooling module that uniquely allows the measurement chamber temperature to be set below the ambient room temperature for more accurate and reliable results.
Tecan has launched the Spark® 20M multimode microplate reader*, offering tailor-made solutions to suit virtually any drug discovery or advanced life science research application. This freely configurable system gives researchers access to new techniques and features intended to enhance and streamline biochemical and cell-based workflows. At the heart of the instrument are Spark’s unique Fusion Optics and a powerful, high frequency xenon flash lamp, which can be combined with your choice of high performance detection modules to ensure a perfect match for your workflow. Options include an enhanced fluorescence module designed to improve sensitivity and increase the speed of high throughput screening, and the newly developed Te-Cool™ cooling module that uniquely allows the measurement chamber temperature to be set below the ambient room temperature for more accurate and reliable results.
Tecan has launched a fully automated affinity purification solution for the extraction of large biomolecules, such as proteins, antibodies and antibody-drug conjugates. This set-up takes advantage of the new Thermo Scientific™ MSIA™ Streptavidin EVO microcolumns, which have been specifically designed for use on Tecan’s proven Freedom EVO® platform. In combination with the Freedom EVO workstation, this solution is ideal for high throughput applications in biopharmaceutical development, clinical research and anti-doping laboratories.